We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Erba Mannheim Acquires Maxmat for Diagnostics Analyzers and Advanced Development

By LabMedica International staff writers
Posted on 25 Oct 2015
Print article
Through its Czech subsidiary Erba Lachema, Erba Mannheim (Mannheim, Germany) has expanded its portfolio by acquiring Maxmat SA, France, a company emphasizing development and manufacturing of medical laboratory devices based on original patented technologies.

On September 21, 2015, Erba Mannheim successfully completed its acquisition of Maxmat, whose blood analyzers are used in clinical laboratories in Western Europe, the USA, and other countries. Maxmat SA France has been renamed to Erba Diagnostics France SARL (Montpellie, France). Erba Diagnostics France will benefit the entire Erba group with its capabilities and knowhow in the field of design and development of analyzers that perform multiple functions in a laboratory spanning different segments of biochemistry, hemostasis, and immunology. Among its product-line is a revolutionary multi-analyzer that can conduct hundreds of different biochemistry, coagulation, and immunology tests on a sample.

Jaroslav Rehurek, Managing Director of Erba Lachema, said: “For us, Maxmat represents a great potential in the area of development of medical devices, and therefore it is supposed to contribute to additional growth of our company. Moreover, we are sure that its analyzers will soon find customers in our markets. Furthermore, the acquisition offers a highly favorable synergy with the current portfolio of our company.”

The acquisition will help shrink development timelines for new advanced technologies and to fulfill the needs of diagnostic laboratories. Erba Diagnostics France (formerly Maxmat SA) will also improve the group’s presence in France and French-speaking North African countries.

Mr. Suresh Vazirani, Chairman and Managing Director of Erba’s Transasia Bio-Medicals Ltd, stated, “We are excited about the new opportunities that are offered by this strategic acquisition. This acquisition will strengthen the group’s plans to emerge as a global leader in IVD.” Erba Group and Erba Diagnostics France (formerly Maxmat SA) have drawn up growth plans based on achieving economies of scale, widening product offering, creating synergy through intra-group coordination, and strengthening after-sales service support and distribution network.

Related Links:

Erba Mannheim
Erba Diagnostics France



Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
17 Beta-Estradiol Assay
17 Beta-Estradiol Assay
New
Liquid Based Cytology Production Machine
LBP-4032

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.